Profile picture

Doctor Ioanna Tzoulaki

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
Follow
Biography
Dr Tzoulaki is a population health scientist with extensive expertise in molecular epidemiology as well track record on precision medicine and prediction models. She has a particular interest in the role of environmental and genetic factors in relation to cardiometabolic diseases and neurodegenerative diseases. She has led large consortia funded by the EC and US NIH as PI and contributes as expert and advisor in several organisms including the European Food and Safety Authority and Public Health England. She has over 140 publications in peer review journals with over 16,000 citations (H index=65).
Logo ESC

Contributor content

Blood pressure, plasma proteins, and cardiovascular diseases: a network Mendelian randomization and observational study
Journal
Blood pressure, plasma proteins, and cardiovascular diseases: a network Mendelian randomization and observational study
9 October 2025
Precision medicine requires precision proteomics: discordance between proteomic and clinical assays in UK Biobank
Journal
Precision medicine requires precision proteomics: discordance between proteomic and clinical assays in UK Biobank
26 September 2025
Reassessing the association between age at menarche and cardiovascular disease: observational and Mendelian randomization analyses
Journal
Reassessing the association between age at menarche and cardiovascular disease: observational and Mendelian randomization analyses
18 March 2025
Sex inequalities in cardiovascular risk prediction
Journal
Sex inequalities in cardiovascular risk prediction
4 June 2024
Blood DNA methylation signature of diet quality and association with cardiometabolic traits
Journal
Blood DNA methylation signature of diet quality and association with cardiometabolic traits
4 October 2023
Serum metabolic signatures of coronary and carotid atherosclerosis and subsequent cardiovascular disease
Journal
Serum metabolic signatures of coronary and carotid atherosclerosis and subsequent cardiovascular disease
18 May 2019

ESC 365 is supported by